Monday, June 5, 2017

Let's Show the FDA the Future of EPP....Our Children!

Let's Show the FDA the Future of EPP....Our Children!

The APF is implementing a new photo campaign to the FDA.  We want them to hear our voices loud and clear and see that we are still here, still struggling, and need immediate approval of Afamelanotide 16mg (Scenesse).  The children are our future - let's tell our story to the FDA through photos and notes from all with EPP that this rare genetic disease has an enormous impact on our daily lives, and has since childhood!  We want them to visualize and hear how you feel and how you would function with a treatment.  EPP doesn't only affect you when you are having a reaction - it affects everything you do and how you must modify your life to AVOID a reaction.  We will keep telling the FDA our stories until we have a treatment!

 Follow the instructions below and we will handle the rest.
  1. SEND A PHOTO by mail or email/scan of your child or you as a child. Choose a photo that shows the impact of this disease - either in full protective "gear", having a reaction, or avoiding a reaction.  ** Please indicate if you would prefer your photo not be identifiable**
  2. Write simple comments or a letter expressing your concerns and how a treatment would impact your life. (Ideas:  Need approval now! Suffering every day! Want to go to school just like everyone else! It hurts like_____ (fill in blank)! Approve Afamelanotide now!)
  3. Include your name, address, and contact information
  4. Send photos and comments to the APF office

American Porphyria Foundation
4900 Woodway Drive, Suite 780
Houston, Texas 77056
      5. We will do the rest!

             "Remember....Research is the key to your cure!"

No comments:

Post a Comment

Judy Snyder Personal Story of AIP

JUDY SNYDER TYPE OF PORPHYRIA Acute Intermittent Porphyria (AIP) It was early April 1997, and I was truly enjoying my job as the...